IL-1RL1

IL-1RL1

IL-1RL1 Overview

Molecule Name
Interleukin-1 receptor-like 1
Synonyms
IL1RL1,DER4,FIT-1,IL33R,ST2,ST2L,ST2V,T1
Drug Development Progress
Drugs in Clinical Trials5
Approved Drugs0
Highest Development StageNDA/BLA
Target Synonym
ST2,IL1RL1,Protein ST2,DER4,T1,Interleukin 1 Receptor Like 1,Homolog Of Mouse Growth Stimulation-Expressed,Interleukin 1 Receptor-Related Protein,Growth Stimulation-Expressed,FIT-1,IL33R,ST2L,ST2V,Interleukin-1 Receptor-Like 1 Protein,EC:3.2.2.6,Interleukin-1 Receptor-Like 1
Background
Interleukin 1 receptor-like 1 (IL1RL1), also known as ST2, DER4, FIT-1, or IL33R, belongs to the interleukin-1 receptor family. Its transmembrane form ST2L contains three immunoglobulin-like C2-type domains and one TIR domain. IL1RL1 (ST2L) serves as the ligand-binding subunit of the receptor for interleukin-33 (IL-33), which also requires IL-1R accessory protein (IL-1RAcP) for signaling. Upon IL-33 stimulation, the receptor complex recruits MYD88, IRAK1, IRAK4, and TRAF6, leading to the phosphorylation of MAPK3/ERK1, MAPK1/ERK2, MAPK14 (p38), and MAPK8 (JNK). IL1RL1 is involved in Th2-type helper T-cell function. The intracellular TIR domain of IL1RL1 can interact with MYD88, IRAK1, IRAK4, and TRAF6.

IL-1RL1 Product List

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
AstegolimabAMG-282; RG-6149; RO-7187807Phase 3 ClinicalAmgen Inc, F. Hoffmann-La Roche Ltd
Coronavirus Disease 2019 (COVID-19); Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
Details
AK-139AK139; AK-139Phase 2 ClinicalKangfang Biotechnology (Cayman) Co Ltd
Asthma; Chronic rhinosinusitis with nasal polyps (CRSwNP); Chronic Urticaria; Dermatitis, Atopic; Hypersensitivity; Prurigo Nodularis; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic; Rhinitis, Allergic, Seasonal
Details
TQC-2938TQC2938; TQC-2938Phase 2 ClinicalNanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group
Asthma; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Seasonal
Details
Recombinant humanized anti-ST2 monoclonal antibody9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911Phase 2 ClinicalMabwell (Shanghai) Bioscience Co Ltd
Asthma; Dermatitis, Atopic; Pulmonary Disease, Chronic Obstructive
Details
NEROFEPhase 1 ClinicalImmune System Key Ltd
Neoplasms; Solid tumours
Details